Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in murine models of chemically- and obesity-induced liver injury
B. Carmona-Hidalgo, I. Gonzalez-Mariscal, A. Garcia-Martin, F. Ruiz-Pino, G. Apendino, M. Tena-Sempere, E. Munoz
This study shows that Δ9-Tetrahydrocannabinolic Acid reduces liver fibrosis and inflammation in mouse models of NAFLD induced by CCl4 or high-fat diet.
bioRxiv · May 11, 2020 · PreprintPharmacology & Toxicology